The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Franziska SchwartzkopffAndreas Ludwig

Abstract

During early inflammation, the chemoattractants neutrophil-activating peptide-2 (NAP-2), platelet-activating factor (PAF), and complement component C5a are rapidly generated within the vasculature and potently induce effector functions in neutrophils, such as chemotaxis and degranulation. We investigated whether these mediators would cross-desensitize each other's activities on isolated neutrophils. We demonstrate that NAP-2 and C5a desensitize degranulation of neutrophils in response to PAF. However, whereas C5a-mediated desensitization correlated with the downregulation of PAF binding sites on neutrophils, NAP-2 did not regulate PAF receptors, nor did it modulate their calcium signaling. In further contrast to C5a, which desensitized PAF-induced neutrophil chemotaxis, NAP-2 did not affect the chemotatic response to PAF. These observations indicate that NAP-2 mediates selective desensitization of PAF-induced neutrophil degranulation by a mechanism downstream from PAF receptors, still allowing migration toward PAF. Thus, a role for NAP-2 may be to limit PAF-dependent vascular tissue damage by preventing degranulation of neutrophils without affecting their migration into the inflamed tissue.

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J R DidsburyR Snyderman
Oct 15, 1991·Biochemical and Biophysical Research Communications·W SchnitzelJ Besemer
Dec 16, 1987·Biochemical and Biophysical Research Communications·A WalzM Baggiolini
Dec 1, 1983·Inflammation·H R CreamerW W Bullock
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E MüllerM Rola-Pleszczynski
Nov 1, 1996·Trends in Pharmacological Sciences·T T ChuangA De Blasi
May 30, 1998·The Journal of Biological Chemistry·R M RichardsonR Snyderman
Feb 26, 1999·The Journal of Biological Chemistry·H AliR Snyderman
Jan 4, 2001·Immunological Reviews·E BrandtH D Flad

❮ Previous
Next ❯

Citations

Jun 3, 2021·Brain Research Bulletin·Junrui YeNaihong Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Y NiimiS Yamane
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Markus SchmuggeJohn Freedman
© 2022 Meta ULC. All rights reserved